HEADER TRANSFERASE 24-AUG-06 2I5J TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TITLE 2 DHBNH, AN RNASE H INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H P66 SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 599-1150; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H P51 SUBUNIT; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 599-1027; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: ISOLATE BH10; SOURCE 5 GENE: GAG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 10 ORGANISM_TAXID: 11676; SOURCE 11 STRAIN: ISOLATE BH10; SOURCE 12 GENE: GAG; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AIDS, HIV, REVERSE TRANSCRIPTASE, RT, RNASE H INHIBITOR, RNHI, KEYWDS 2 STRUCTURE-BASED DRUG DESIGN, PROTEIN-INHIBITOR COMPLEX, DRUG KEYWDS 3 RESISTANCE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.M.HIMMEL,S.G.SARAFIANOS,J.L.KNIGHT,R.M.LEVY,E.ARNOLD REVDAT 7 30-AUG-23 2I5J 1 REMARK REVDAT 6 20-OCT-21 2I5J 1 SEQADV HETSYN REVDAT 5 29-JUL-20 2I5J 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL LINK SITE ATOM REVDAT 4 18-OCT-17 2I5J 1 REMARK REVDAT 3 24-FEB-09 2I5J 1 VERSN REVDAT 2 24-APR-07 2I5J 1 JRNL REVDAT 1 05-DEC-06 2I5J 0 JRNL AUTH D.M.HIMMEL,S.G.SARAFIANOS,S.DHARMASENA,M.M.HOSSAIN, JRNL AUTH 2 K.MCCOY-SIMANDLE,T.ILINA,A.D.CLARK,J.L.KNIGHT,J.G.JULIAS, JRNL AUTH 3 P.K.CLARK,K.KROGH-JESPERSEN,R.M.LEVY,S.H.HUGHES,M.A.PARNIAK, JRNL AUTH 4 E.ARNOLD JRNL TITL HIV-1 REVERSE TRANSCRIPTASE STRUCTURE WITH RNASE H INHIBITOR JRNL TITL 2 DIHYDROXY BENZOYL NAPHTHYL HYDRAZONE BOUND AT A NOVEL SITE. JRNL REF ACS CHEM.BIOL. V. 1 702 2006 JRNL REFN ISSN 1554-8929 JRNL PMID 17184135 JRNL DOI 10.1021/CB600303Y REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.M.HIMMEL,K.DAS,A.D.CLARK JR.,S.H.HUGHES,A.BENJAHAD, REMARK 1 AUTH 2 S.OUMOUCH,J.GUILLEMONT,S.COUPA,A.PONCELET,I.CSOKA,C.MEYER, REMARK 1 AUTH 3 K.ANDRIES,C.H.NGUYEN,D.S.GRIERSON,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES FOR HIV-1 REVERSE TRANSCRIPTASE IN REMARK 1 TITL 2 COMPLEXES WITH THREE PYRIDINONE DERIVATIVES: A NEW CLASS OF REMARK 1 TITL 3 NON-NUCLEOSIDE INHIBITORS EFFECTIVE AGAINST A BROAD RANGE OF REMARK 1 TITL 4 DRUG-RESISTANT STRAINS REMARK 1 REF J.MED.CHEM. V. 48 7582 2005 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 16302798 REMARK 1 DOI 10.1021/JM0500323 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.G.SARAFIANOS,K.DAS,C.TANTILLO,A.D.CLARK JR.,J.DING, REMARK 1 AUTH 2 J.M.WHITCOMB,P.L.BOYER,S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX REMARK 1 TITL 2 WITH A POLYPURINE TRACT RNA:DNA REMARK 1 REF EMBO J. V. 20 1449 2001 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 11250910 REMARK 1 DOI 10.1093/EMBOJ/20.6.1449 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.DAS,A.D.CLARK JR.,P.J.LEWI,J.HEERES,M.R.DE JONGE, REMARK 1 AUTH 2 L.M.H.KOYMANS,H.M.VINKERS,F.DAEYAERT,D.W.LUDOVICI,M.J.KUKLA, REMARK 1 AUTH 3 B.DE CORTE,R.W.KAVASH,C.Y.HO,H.YE,M.A.LICHTENSTEIN, REMARK 1 AUTH 4 K.ANDRIES,R.PAUWELS,M.-P.DE BETHUNE,P.L.BOYER,P.CLARK, REMARK 1 AUTH 5 S.H.HUGHES,P.A.J.JANSSEN,E.ARNOLD REMARK 1 TITL ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN REMARK 1 TITL 2 STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE) AND REMARK 1 TITL 3 RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT REMARK 1 TITL 4 ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND REMARK 1 TITL 5 DRUG-RESISTANT HIV-1 VARIANTS REMARK 1 REF J.MED.CHEM. V. 47 2550 2004 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.DING,K.DAS,Y.HSIOU,S.G.SARAFIANOS,A.D.CLARK JR., REMARK 1 AUTH 2 A.JACOBO-MOLINA,C.TANTILLO,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE AND FUNCTIONAL IMPLICATIONS OF THE POLYMERASE REMARK 1 TITL 2 ACTIVE SITE REGION IN A COMPLEX OF HIV-1 RT WITH A REMARK 1 TITL 3 DOUBLE-STRANDED DNA TEMPLATE-PRIMER AND AN ANTIBODY FAB REMARK 1 TITL 4 FRAGMENT AT 2.8 A RESOLUTION. REMARK 1 REF J.MOL.BIOL. V. 284 1095 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 5 REMARK 1 AUTH Y.HSIOU,J.DING,K.DAS,A.D.CLARK JR.,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF UNLIGANDED HIV-1 REVERSE TRANSCRIPTASE T 2.7 A REMARK 1 TITL 2 RESOLUTION: IMPLICATIONS OF CONFORMATIONAL HANGES FOR REMARK 1 TITL 3 POLYMERIZATION AND INHIBITION MECHANISMS REMARK 1 REF STRUCTURE V. 4 853 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 197616.641 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.7 REMARK 3 NUMBER OF REFLECTIONS : 23575 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.800 REMARK 3 FREE R VALUE TEST SET COUNT : 670 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 64.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2800 REMARK 3 BIN R VALUE (WORKING SET) : 0.4030 REMARK 3 BIN FREE R VALUE : 0.4270 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 77 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.049 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7964 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 92.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.92000 REMARK 3 B22 (A**2) : -7.69000 REMARK 3 B33 (A**2) : -2.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 13.75000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.83 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.82 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.340 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 8.700 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 12.870; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 12.400; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 16.340; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.28 REMARK 3 BSOL : 52.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : ALLPROSTH.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : ALLPROSTH.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2I5J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1000039163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24789 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.150 REMARK 200 RESOLUTION RANGE LOW (A) : 26.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.80500 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2BE2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM IMIDAZOLE PH 6.4, 100 MM REMARK 280 AMMONIUM SULFATE, 15 MM MAGNESIUM SULFATE, 0.6 MM DHBNH, 4% REMARK 280 GLUCOSE, 10.5% PEG 8000, 2 MM NAN3, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 112.40750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.44800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 112.40750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.44800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 67 N - CA - C ANGL. DEV. = -21.4 DEGREES REMARK 500 SER A 68 N - CA - C ANGL. DEV. = 27.7 DEGREES REMARK 500 PRO A 150 CB - CA - C ANGL. DEV. = 15.3 DEGREES REMARK 500 PRO A 217 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 LYS A 219 N - CA - C ANGL. DEV. = -26.4 DEGREES REMARK 500 GLN A 222 N - CA - C ANGL. DEV. = 27.2 DEGREES REMARK 500 GLY A 285 N - CA - C ANGL. DEV. = -21.0 DEGREES REMARK 500 PRO A 412 N - CA - C ANGL. DEV. = 16.6 DEGREES REMARK 500 ARG B 211 O - C - N ANGL. DEV. = -10.6 DEGREES REMARK 500 HIS B 221 N - CA - C ANGL. DEV. = -17.3 DEGREES REMARK 500 THR B 419 N - CA - C ANGL. DEV. = 17.0 DEGREES REMARK 500 PRO B 420 N - CA - C ANGL. DEV. = -15.7 DEGREES REMARK 500 LEU B 422 N - CA - C ANGL. DEV. = -22.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 31.35 -83.10 REMARK 500 PRO A 14 109.86 -49.54 REMARK 500 LYS A 20 49.06 -101.26 REMARK 500 LEU A 26 -70.83 -112.67 REMARK 500 THR A 27 -155.12 -145.30 REMARK 500 GLU A 28 -12.09 -147.36 REMARK 500 ILE A 31 27.93 -78.17 REMARK 500 LYS A 32 -58.53 -127.88 REMARK 500 GLU A 44 0.91 -67.37 REMARK 500 PRO A 52 36.26 -83.12 REMARK 500 ASP A 76 79.94 -106.38 REMARK 500 PHE A 77 0.93 -64.49 REMARK 500 ARG A 78 -38.48 -29.56 REMARK 500 GLN A 85 156.77 -49.74 REMARK 500 VAL A 90 -178.47 -54.35 REMARK 500 GLN A 91 109.99 -53.14 REMARK 500 PRO A 95 94.32 -66.96 REMARK 500 ALA A 98 -6.00 -57.62 REMARK 500 ALA A 114 -75.40 -41.84 REMARK 500 GLU A 122 -13.60 -45.62 REMARK 500 PRO A 133 176.60 -56.04 REMARK 500 PHE A 160 -70.95 -78.46 REMARK 500 SER A 162 -77.68 -59.23 REMARK 500 LYS A 166 -1.69 -54.06 REMARK 500 PRO A 176 9.84 -61.48 REMARK 500 TYR A 183 110.76 -161.55 REMARK 500 MET A 184 -147.18 59.70 REMARK 500 TRP A 212 38.47 -99.47 REMARK 500 PRO A 217 -175.47 -61.59 REMARK 500 ASP A 218 103.94 -177.97 REMARK 500 LYS A 220 -36.56 -155.22 REMARK 500 HIS A 221 97.21 -166.18 REMARK 500 GLN A 222 -26.74 -37.75 REMARK 500 TRP A 229 98.27 -165.47 REMARK 500 MET A 230 13.78 56.96 REMARK 500 ASP A 237 19.55 -144.70 REMARK 500 PRO A 272 106.45 -59.91 REMARK 500 VAL A 276 25.20 -147.04 REMARK 500 LEU A 283 5.87 -64.20 REMARK 500 LYS A 287 59.25 -95.63 REMARK 500 VAL A 292 87.85 -66.72 REMARK 500 GLN A 340 122.15 -172.20 REMARK 500 LYS A 350 154.96 179.79 REMARK 500 ARG A 358 23.21 48.09 REMARK 500 HIS A 361 104.99 -162.23 REMARK 500 VAL A 381 -60.54 -98.12 REMARK 500 LYS A 390 77.56 -116.40 REMARK 500 PRO A 392 53.89 -67.78 REMARK 500 TRP A 406 -16.21 -43.07 REMARK 500 TRP A 410 75.68 -159.28 REMARK 500 REMARK 500 THIS ENTRY HAS 117 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 25 LEU A 26 -143.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG B 211 19.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A5001 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD1 REMARK 620 2 ASP A 498 OD1 100.9 REMARK 620 N 1 REMARK 630 REMARK 630 MOLECULE TYPE: OLIGOSACCHARIDE NUTRIENT REMARK 630 MOLECULE NAME: ALPHA-D-GLUCOPYRANOSE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 GLC A 2001 REMARK 630 GLC A 2002 REMARK 630 GLC B 2003 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: NULL REMARK 630 DETAILS: OLIGOSACCHARIDE WITH REDUCING-END-TO-REDUCING-END REMARK 630 GLYCOSIDIC BOND DBREF 2I5J A 1 552 UNP P03366 POL_HV1B1 599 1150 DBREF 2I5J B 1 429 UNP P03366 POL_HV1B1 599 1027 SEQADV 2I5J SER A 280 UNP P03366 CYS 878 ENGINEERED MUTATION SEQADV 2I5J SER B 280 UNP P03366 CYS 878 ENGINEERED MUTATION SEQRES 1 A 552 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 552 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 552 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 552 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 552 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 552 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 552 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 552 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 552 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 552 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 552 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 552 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 552 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 552 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 552 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 552 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 552 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 552 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 552 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 552 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 552 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 552 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 552 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 552 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 552 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 552 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 552 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 552 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 552 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 552 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 552 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 552 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 552 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 552 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 552 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 552 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 552 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 552 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 552 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 552 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 552 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 552 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 552 GLN VAL ASP LYS LEU VAL SEQRES 1 B 429 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 429 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 429 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 429 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 429 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 429 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 429 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 429 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 429 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 429 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 429 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 429 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 429 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 429 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 429 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 429 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 429 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 429 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 429 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 429 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 429 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 429 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 429 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 429 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 429 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 429 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 429 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 429 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 429 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 429 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 429 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 429 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 429 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU HET GLC C 1 11 HET FRU C 2 12 HET GLC D 1 11 HET FRU D 2 12 HET GLC A2001 12 HET GLC A2002 12 HET K05 A4001 25 HET MG A5001 1 HET GLC B2003 12 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FRU BETA-D-FRUCTOFURANOSE HETNAM K05 (E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL) HETNAM 2 K05 METHYLENE]BENZOHYDRAZIDE HETNAM MG MAGNESIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN FRU BETA-D-FRUCTOSE; D-FRUCTOSE; FRUCTOSE FORMUL 3 GLC 5(C6 H12 O6) FORMUL 3 FRU 2(C6 H12 O6) FORMUL 7 K05 C19 H16 N2 O4 FORMUL 8 MG MG 2+ FORMUL 10 HOH *36(H2 O) HELIX 1 1 LYS A 32 GLY A 45 1 14 HELIX 2 2 PHE A 77 LYS A 82 1 6 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 GLY A 155 ASN A 175 1 21 HELIX 6 6 GLU A 194 TRP A 212 1 19 HELIX 7 7 THR A 253 SER A 268 1 16 HELIX 8 8 VAL A 276 LYS A 281 1 6 HELIX 9 9 THR A 296 LYS A 311 1 16 HELIX 10 10 ASN A 363 TRP A 383 1 21 HELIX 11 11 GLN A 394 THR A 403 1 10 HELIX 12 12 THR A 473 SER A 489 1 17 HELIX 13 13 SER A 499 GLN A 507 1 9 HELIX 14 14 SER A 515 LYS A 528 1 14 HELIX 15 15 GLN A 547 VAL A 552 1 6 HELIX 16 16 THR B 27 GLY B 45 1 19 HELIX 17 17 PHE B 77 ARG B 83 1 7 HELIX 18 18 THR B 84 GLU B 89 1 6 HELIX 19 19 GLY B 112 PHE B 116 5 5 HELIX 20 20 ASP B 121 TYR B 127 5 7 HELIX 21 21 SER B 134 GLU B 138 5 5 HELIX 22 22 LYS B 154 ASN B 175 1 22 HELIX 23 23 GLN B 197 TRP B 212 1 16 HELIX 24 24 THR B 253 TRP B 266 1 14 HELIX 25 25 ALA B 267 ILE B 270 5 4 HELIX 26 26 ALA B 299 LEU B 310 1 12 HELIX 27 27 ASN B 363 TRP B 383 1 21 HELIX 28 28 GLN B 394 TRP B 406 1 13 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 LYS A 64 0 SHEET 2 B 2 TRP A 71 VAL A 75 -1 O LEU A 74 N PHE A 61 SHEET 1 C 3 LEU A 109 ASP A 110 0 SHEET 2 C 3 ASP A 186 LEU A 187 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 GLN A 182 TYR A 183 -1 N TYR A 183 O ASP A 186 SHEET 1 D 3 PHE A 227 TRP A 229 0 SHEET 2 D 3 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 D 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 E 5 LYS A 347 TYR A 354 0 SHEET 2 E 5 TRP A 337 GLU A 344 -1 N TRP A 337 O TYR A 354 SHEET 3 E 5 ILE A 326 LYS A 331 -1 N ILE A 326 O TYR A 342 SHEET 4 E 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 E 5 TRP A 414 PHE A 416 1 O GLU A 415 N PHE A 389 SHEET 1 F 5 GLN A 464 THR A 470 0 SHEET 2 F 5 LEU A 452 THR A 459 -1 N GLY A 453 O LEU A 469 SHEET 3 F 5 THR A 439 ASN A 447 -1 N ASN A 447 O LEU A 452 SHEET 4 F 5 GLU A 492 THR A 497 1 O VAL A 496 N PHE A 440 SHEET 5 F 5 LYS A 530 TRP A 535 1 O ALA A 534 N ILE A 495 SHEET 1 G 3 ILE B 47 LYS B 49 0 SHEET 2 G 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 G 3 ALA B 129 ILE B 132 -1 N PHE B 130 O TYR B 144 SHEET 1 H 2 VAL B 60 LYS B 64 0 SHEET 2 H 2 TRP B 71 VAL B 75 -1 O LEU B 74 N PHE B 61 SHEET 1 I 4 VAL B 179 TYR B 183 0 SHEET 2 I 4 ASP B 186 SER B 191 -1 O TYR B 188 N TYR B 181 SHEET 3 I 4 SER B 105 ASP B 110 -1 N LEU B 109 O LEU B 187 SHEET 4 I 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 J 5 LYS B 347 TYR B 354 0 SHEET 2 J 5 TRP B 337 GLU B 344 -1 N ILE B 341 O LEU B 349 SHEET 3 J 5 ILE B 326 LYS B 331 -1 N ILE B 326 O TYR B 342 SHEET 4 J 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 J 5 GLU B 413 PHE B 416 1 O GLU B 413 N PHE B 389 LINK C1 GLC C 1 O2 FRU C 2 1555 1555 1.41 LINK C1 GLC D 1 O2 FRU D 2 1555 1555 1.42 LINK OD1 ASP A 443 MG MG A5001 1555 1555 1.94 LINK OD1 ASP A 498 MG MG A5001 1555 1555 2.41 CISPEP 1 PRO A 420 PRO A 421 0 -0.01 CRYST1 224.815 68.896 104.662 90.00 106.48 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004448 0.000000 0.001316 0.00000 SCALE2 0.000000 0.014515 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009964 0.00000